Andrzej Kołtan

568 total citations
34 papers, 180 citations indexed

About

Andrzej Kołtan is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Andrzej Kołtan has authored 34 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 14 papers in Pediatrics, Perinatology and Child Health and 10 papers in Immunology. Recurrent topics in Andrzej Kołtan's work include Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Immune Cell Function and Interaction (7 papers). Andrzej Kołtan is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Immune Cell Function and Interaction (7 papers). Andrzej Kołtan collaborates with scholars based in Poland, United States and Latvia. Andrzej Kołtan's co-authors include Mariusz Wysocki, Robert Dębski, Sylwia Kołtan, Jan Styczyński, Jerzy Kowalczyk, Grażyna Odrowąż‐Sypniewska, Grażyna Karolczyk, Katarzyna Derwich, Maryna Krawczuk‐Rybak and Joanna Trelińska and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Medicine.

In The Last Decade

Andrzej Kołtan

33 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrzej Kołtan Poland 9 84 60 51 40 39 34 180
Elva Jiménez‐Hernández Mexico 10 105 1.3× 68 1.1× 79 1.5× 95 2.4× 63 1.6× 33 312
Federico Verzegnassi Italy 9 42 0.5× 37 0.6× 39 0.8× 30 0.8× 25 0.6× 15 182
Yael Klionsky United States 8 40 0.5× 42 0.7× 42 0.8× 30 0.8× 55 1.4× 18 196
Bénedicte Bruno France 10 53 0.6× 73 1.2× 132 2.6× 91 2.3× 54 1.4× 24 280
Lisa Murray United States 7 45 0.5× 58 1.0× 96 1.9× 19 0.5× 31 0.8× 12 195
Anna Pieczonka Poland 9 60 0.7× 45 0.8× 107 2.1× 45 1.1× 32 0.8× 31 202
Christophe Peczynski France 8 99 1.2× 42 0.7× 202 4.0× 61 1.5× 45 1.2× 21 251
Tiziana Coliva Italy 8 143 1.7× 40 0.7× 190 3.7× 63 1.6× 55 1.4× 11 309
Hans-Juergen Laws Germany 8 78 0.9× 31 0.5× 47 0.9× 55 1.4× 18 0.5× 13 229
Sabina Sufliarska Slovakia 6 57 0.7× 24 0.4× 95 1.9× 32 0.8× 10 0.3× 15 154

Countries citing papers authored by Andrzej Kołtan

Since Specialization
Citations

This map shows the geographic impact of Andrzej Kołtan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Kołtan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Kołtan more than expected).

Fields of papers citing papers by Andrzej Kołtan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Kołtan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Kołtan. The network helps show where Andrzej Kołtan may publish in the future.

Co-authorship network of co-authors of Andrzej Kołtan

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Kołtan. A scholar is included among the top collaborators of Andrzej Kołtan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Kołtan. Andrzej Kołtan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sędek, Łukasz, Iwona Malinowska, Joanna Zawitkowska, et al.. (2022). Expression of CD73 on leukemic blasts increases during follow-up – a promising candidate marker for minimal residual disease detection in pediatric B-cell precursor acute lymphoblastic leukemia. Central European Journal of Immunology. 47(1). 84–91. 2 indexed citations
3.
Sędek, Łukasz, Bogdan Mazur, Katarzyna Muszyńska‐Rosłan, et al.. (2021). Multicolor flow cytometry immunophenotypingand characterization of aneuploidy in pediatricB-cell precursor acute lymphoblastic leukemia. Central European Journal of Immunology. 46(3). 365–374. 6 indexed citations
4.
Janczar, Szymon, Anna Klukowska, Paweł Łaguna, et al.. (2020). Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland. Thrombosis Research. 193. 9–14. 8 indexed citations
5.
Zawitkowska, Joanna, Monika Lejman, Agnieszka Zaucha‐Prażmo, et al.. (2019). Grade 3 and 4 Toxicity Profiles During Therapy of Childhood Acute Lymphoblastic Leukemia. In Vivo. 33(4). 1333–1339. 15 indexed citations
6.
Pogorzała, Monika, et al.. (2019). Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress. Anticancer Research. 39(9). 5203–5207. 16 indexed citations
7.
Zawitkowska, Joanna, Monika Lejman, Agnieszka Zaucha‐Prażmo, et al.. (2018). Clinical characteristics and analysis of treatment result in children with Ph‐positive acute lymphoblastic leukaemia in Poland between 2005 and 2017. European Journal Of Haematology. 101(4). 542–548. 5 indexed citations
8.
Krawczuk‐Rybak, Maryna, Maciej Niedźwiecki, Katarzyna Drabko, et al.. (2018). Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas. Advances in Clinical and Experimental Medicine. 27(1). 91–98. 8 indexed citations
9.
Chaber, Radosław, Grażyna Wróbel, Jadwiga Małdyk, et al.. (2016). Clinical features and treatment outcomes of peripheral T-cell lymphoma in children. A current data report from Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG). Advances in Medical Sciences. 61(2). 311–316. 11 indexed citations
10.
Dawidowska, Małgorzata, Łukasz Sędek, Aleksandra Szczepankiewicz, et al.. (2016). Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL. Scientific Reports. 6(1). 29427–29427. 12 indexed citations
11.
Kołtan, Sylwia, Robert Dębski, Andrzej Kołtan, et al.. (2015). Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia. Medicine. 94(52). e2369–e2369. 8 indexed citations
12.
Kołtan, Andrzej, Sylwia Kołtan, Robert Dębski, et al.. (2014). An assessment of selected immune parameters of patients with Hodgkin's disease. Molecular and Clinical Oncology. 3(1). 237–243. 1 indexed citations
13.
Burduk, Paweł, et al.. (2012). Nasolacrimal duct obstruction after toxic epidermal necrolysis. Otolaryngologia Polska. 66(2). 148–151. 3 indexed citations
14.
Pietrzyk, Jacek J, Mirosław Bik-Multanowski, Walentyna Balwierz, et al.. (2008). Additional genetic risk factor for death in children with acute lymphoblastic leukemia: A common polymorphism of the MTHFR gene. Pediatric Blood & Cancer. 52(3). 364–368. 15 indexed citations
15.
Dębski, Robert, et al.. (2008). The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL. Annals of Hematology. 87(12). 991–1002. 10 indexed citations
16.
Kołtan, Sylwia, Andrzej Kołtan, Mariusz Wysocki, Robert Dębski, & Jan Styczyński. (2005). Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants. Journal of Hospital Infection. 60(1). 73–77. 5 indexed citations
17.
Derwich, Katarzyna, Jacek Wachowiak, Anna Balcerska, et al.. (2004). [Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].. PubMed. 61 Suppl 2. 49–52. 4 indexed citations
18.
Kołtan, Sylwia, Jan Styczyński, Mariusz Wysocki, et al.. (2004). Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years.. PubMed. 89(2). 251–2. 3 indexed citations
19.
Wysocki, Mariusz, et al.. (2003). Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia. Medical and Pediatric Oncology. 41(6). 578–580. 9 indexed citations
20.
Styczyński, Jan, Andrzej Kołtan, Olga Haus, & Mariusz Wysocki. (2002). DIFFERENTIAL CHEMOSENSITIVITY IN A CHILD WITH CONGENITAL RELAPSING ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Hematology and Oncology. 19(5). 355–360. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elva Jiménez‐Hernández Breakdown of academic impact, for papers by Federico Verzegnassi Breakdown of academic impact, for papers by Yael Klionsky Breakdown of academic impact, for papers by Bénedicte Bruno Breakdown of academic impact, for papers by Lisa Murray Breakdown of academic impact, for papers by Anna Pieczonka Breakdown of academic impact, for papers by Christophe Peczynski Breakdown of academic impact, for papers by Tiziana Coliva Breakdown of academic impact, for papers by Hans-Juergen Laws Breakdown of academic impact, for papers by Sabina Sufliarska
Rankless by CCL
2026